Evaluation of direct-acting antivirals and antiretroviral therapy for HIV-HCV coinfected patients in the United States
The human immunodeficiency virus (HIV)-hepatitis C virus (HCV) coinfection is one of the most common coinfections across the globe. There are over 2 million people living with both HIV and HCV worldwide. In the United States, HIV-HCV coinfections present a huge public health issue. There are several...
Main Author: | Rivera, Josef Kyle Concepcion |
---|---|
Other Authors: | Spencer, Jean L. |
Language: | en_US |
Published: |
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/42190 |
Similar Items
-
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?
by: Giuseppe Bruno, et al.
Published: (2017-09-01) -
The Prevalence and Impact of Hepatic Steatosis on Response to Direct-Acting Antiviral Therapy in HIV–HCV Coinfection
by: Leigh P. Johnson, et al.
Published: (2020-04-01) -
Molecular Study of Occult Hepatitis C Infection among Iranian Hemophilia Patients Treated with Direct-acting Antiviral Agents
by: Elnaz Agi, et al.
Published: (2020-01-01) -
HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
by: Óscar Brochado-Kith, et al.
Published: (2021-08-01) -
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
by: Mohamed Mohei El Badry, et al.
Published: (2020-11-01)